Assignee
NEURALTUS PHARMACEUTICALS INC
US·2 granted patents·4 pending applications·26 citations·filing 2014–2016
Top patents by PatentIndex Score
6 records- 0191US9839650B2Chlorite formulations, and methods of preparation and use thereofNEURALTUS PHARMACEUTICALS INC·Filed 2016·Granted Dec 12, 2017·10 cites·16 claims
- 0290US9579346B2Treatment of macrophage-related disordersNEURALTUS PHARMACEUTICALS INC·Filed 2014·Granted Feb 28, 2017·16 cites·19 claims
- 0349US2015044193A1COMPOSITIONS AND METHODS FOR THE TREATMENT OF ALTERED a-SYNUCLEIN FUNCTIONNEURALTUS PHARMACEUTICALS INC·Filed 2014·Application pending·0 cites
- 0445US2015202185A1Compositions and methods for treating lysosomal disordersNEURALTUS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
- 0537US2019060359A1Treatment of neurodegenerative disease with sodium chloriteNEURALTUS PHARMACEUTICALS INC·Filed 2016·Application pending·0 cites
- 0629US2017106017A1Methods and compositions for treatment of macrophage-related disordersNEURALTUS PHARMACEUTICALS INC·Filed 2015·Application pending·0 cites
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →